Several studies have highlighted the role of EMT in facilitating drug resistance in tumors.[31] Based on this association, we investigated the potential therapeutic implications of targeting NSUN5 in HCC treatment. The gene discussed is NSUN5; the disease is hepatocellular carcinoma.